Chapter review

Fitzgerald PMHNP board review. ch11. Substance-related Disorders. This is drive 7 of 8. When I say Pause. Answer. wait, then I will give the answer. New section. Laboratory Findings in AUD (Table 11-5). Topic. MCV and Macrocytosis. Bottom Line Summary. - **Mild macrocytosis without anemia** develops in approximately 60% of individuals who consume heavy amounts of alcohol, defined as 3 or more drinks per day for women and 5 or more drinks per day for men source 1. - A classic lab profile presents an elevated **mean corpuscular volume** (MCV) of 105 fL (normal reference range 80 to 96 fL) alongside a completely normal **hemoglobin** of 15 g/dL and normal **hematocrit** of 45% source 2. - **Macrocytosis** resolves within 2 to 3 months of complete sobriety, matching the 120-day lifespan and turnover rate of circulating red blood cells source 1. - An elevated **aspartate aminotransferase** (AST) greater than **alanine aminotransferase** (ALT) in a 2:1 ratio (e.g., AST of 83 U/L and ALT of 50 U/L; normal reference range 0 to 40 U/L) reflects direct hepatic toxicity from alcohol and normalizes within 1 to 3 months of total abstinence [3-5]. - **Isolated hypertriglyceridemia** presents with markedly elevated triglycerides (e.g., 325 mg/dL; desirable goal 150 mg/dL or less) despite near-normal HDL (58 mg/dL) and LDL (120 mg/dL), resolving fastest within 1 to 2 months of sobriety [6, 7]. - Objective blood markers (MCV, AST, ALT, and triglycerides) provide essential clinical evidence to detect chronic heavy drinking and monitor longitudinal sobriety when patients exhibit **denial** or underreport consumption source 8. - **Acamprosate** is the first-line pharmacotherapy for maintaining abstinence in patients with alcohol use disorder and co-occurring moderate-to-severe liver disease, because it is excreted by the kidneys, unlike **naltrexone** which is contraindicated in liver failure or acute hepatitis [9-11]. Laboratory Findings in Alcohol Use Disorder (Table 11-5). Spoken Teaching of Laboratory Patterns and Sobriety Timelines. Evaluating **alcohol use disorder** requires analyzing three distinct laboratory signals that reflect systemic toxicity and clear on predictable timelines once total abstinence is achieved [3, 8]. The first pattern is **macrocytosis without anemia** source 1. Heavy drinking, defined as 3 or more drinks per day in women or 5 or more drinks per day in men, causes erythrocyte enlargement in about 60% of patients source 1. On a complete blood count, the **mean corpuscular volume** elevates above the upper normal limit of 96 fL to levels such as 105 fL, while the **hemoglobin** remains normal at 15 g/dL and **hematocrit** remains normal at 45% source 2. Because circulating red blood cells survive approximately 120 days, this macrocytosis takes 2 to 3 months of verified sobriety to completely resolve source 1. The second pattern is the **hepatic transaminase ratio** [3, 4]. Alcohol toxicity causes **AST** to rise higher than **ALT**, typically remaining within 2 to 3 times the upper limit of normal source 3. For example, a patient with a 10-year history of heavy drinking may present with an **AST** of 83 U/L and an **ALT** of 50 U/L against a normal reference range of 0 to 40 U/L source 5. In contrast, when **ALT** is higher than **AST**, clinicians must suspect viral hepatitis or a non-alcoholic liver etiology source 4. Serum transaminase elevations from alcohol resolve within 1 to 3 months of total abstinence source 4. The third pattern is **isolated hypertriglyceridemia** source 6. Heavy alcohol intake impairs lipid metabolism, causing **triglycerides** to surge to levels like 325 mg/dL (where the desirable threshold is 150 mg/dL or less) while **HDL** remains around 58 mg/dL and **LDL** remains around 120 mg/dL source 7. Serum triglycerides clear most rapidly, returning to baseline within 1 to 2 months of sobriety source 6. Comparing these three recovery windows provides a clear sequence for tracking recovery: **triglycerides** resolve first in 1 to 2 months, **transaminases** normalize in 1 to 3 months, and **MCV** normalizes last in 2 to 3 months [1, 4, 6]. Clinical Signposts and Exam Pearls. Safety Alert. **Safety alert**: Mild macrocytosis in **alcohol use disorder** represents direct bone marrow toxicity or poor dietary intake, but it must be distinguished from severe megaloblastic anemia or gastrointestinal bleeding [1, 12]. If a patient presents with macrocytosis accompanied by falling **hemoglobin** or **hematocrit**, immediately assess for acute upper GI bleeding from esophageal varices or severe peptic ulceration source 12. Additionally, before administering intravenous glucose to a malnourished patient with alcohol use disorder, always administer high-dose **thiamine** first to prevent irreversible **Wernicke encephalopathy** or **Korsakoff syndrome** [13, 14]. Board Trap. **Board trap**: Exam writers test your ability to differentiate causes of transaminase elevation and select safe medications [4, 11]. An **AST** greater than **ALT** indicates alcohol-induced liver injury, whereas an **ALT** greater than **AST** points toward viral hepatitis source 4. Furthermore, test writers will present a patient with elevated liver enzymes or liver disease who needs craving-reduction therapy [10, 11]. Choosing **naltrexone** in severe liver disease or acute hepatitis is a classic board trap because **naltrexone** carries hepatotoxicity risk [11, 15]. The correct choice is **acamprosate**, which is cleared renally and safe in hepatic impairment [9, 11]. A second board trap involves prescribing **naltrexone** to a patient scheduled for surgery or dental procedures requiring opioid analgesics; **naltrexone** blocks opioid receptors and precipitates severe acute withdrawal if opioids are administered [15-17]. First-Line. **First-line**: Order a baseline **complete blood count**, **hepatic panel**, and **lipid panel** during initial psychiatric assessment when alcohol misuse is suspected, and use serial **MCV** and **transaminase** levels during follow-up to objectively verify reported sobriety [3, 8]. For pharmacotherapy, **acamprosate** or **naltrexone** are first-line agents for moderate-to-severe **alcohol use disorder**, with **acamprosate** chosen if the patient has liver disease or requires opioid medications [9, 17-19]. Sample Board Exam Questions for This Leaf. Question 1. A 58-year-old man with a 10-year history of alcohol misuse presents for a routine health maintenance examination. Laboratory evaluation reveals a hemoglobin of 15 g/dL, hematocrit of 45%, mean corpuscular volume (MCV) of 105 fL (normal 80 to 96 fL), AST of 83 U/L (normal 0 to 40 U/L), and ALT of 50 U/L (normal 0 to 40 U/L). He asks how long it will take for his blood counts to return to normal if he maintains complete sobriety. What is the most accurate response? A) 1 to 2 weeks B) 1 to 2 months C) 2 to 3 months D) 6 to 12 months Pause. Answer: C **Why it is correct**: Mild macrocytosis without anemia occurs in about 60% of heavy drinkers and resolves within 2 to 3 months of complete sobriety due to the 120-day lifespan and turnover rate of circulating red blood cells [1, 2]. **Why the other choices are wrong**: - A is incorrect because red blood cell turnover requires more than a few weeks to reflect normalized erythropoiesis. - B is incorrect because 1 to 2 months is the resolution timeframe for isolated hypertriglyceridemia, whereas MCV normalization requires 2 to 3 months [1, 6]. - D is incorrect because 6 to 12 months exceeds the necessary timeframe for macrocytosis reversal in uncomplicated alcohol cessation source 1. **Test-taking pearl**: Memorize the laboratory recovery windows for alcohol cessation: triglycerides resolve in 1 to 2 months, AST and ALT normalize in 1 to 3 months, and MCV normalizes in 2 to 3 months [1, 4, 6]. Question 2. A 54-year-old man with a history of alcohol use disorder and moderate chronic liver disease presents for psychiatric follow-up. He has been abstinent for 3.5 years but reports recent severe life stressors, including the death of a sibling and job loss, which have triggered intense cravings to drink alcohol. He requests medication to help maintain his abstinence. Which medication is most appropriate to initiate? A) Disulfiram B) Naltrexone C) Clonidine D) Acamprosate Pause. Answer: D **Why it is correct**: Acamprosate helps maintain abstinence by restoring GABA and glutamate balance; because it is excreted renally, it can be safely administered to patients with moderate liver disease [9-11]. **Why the other choices are wrong**: - A is incorrect because disulfiram is an aversion agent rather than initial relapse-prevention therapy and requires extreme caution in liver disease [19, 20]. - B is incorrect because naltrexone undergoes hepatic metabolism and is contraindicated in acute hepatitis or liver failure [11, 15]. - C is incorrect because clonidine is an alpha-2 agonist used for autonomic symptom management in acute opioid or alcohol withdrawal, not long-term craving suppression [11, 21]. **Test-taking pearl**: In board scenarios featuring alcohol use disorder with liver impairment, acamprosate is the safe, renal-cleared drug of choice [9, 11]. Question 3. A 44-year-old woman preparing for discharge from an inpatient substance rehabilitation facility wishes to start medication for alcohol abstinence. She notes that she has extensive dental surgery scheduled next month that will require postoperative pain management. Which medication is strictly contraindicated for this patient? A) Disulfiram B) Naltrexone C) Acamprosate D) Sertraline Pause. Answer: B **Why it is correct**: Naltrexone is an opioid receptor antagonist; administering naltrexone to a patient who requires opioid analgesics for scheduled surgical or dental procedures will block pain relief or precipitate acute withdrawal [15-17]. **Why the other choices are wrong**: - A is incorrect because disulfiram does not interact with opioid analgesics, though it requires avoiding alcohol-containing preparations [17, 19]. - C is incorrect because acamprosate does not bind opioid receptors and is safe to use alongside necessary surgical analgesia [9, 17]. - D is incorrect because sertraline is an SSRI used for depression or anxiety rather than primary alcohol craving management, but it is not contraindicated for dental procedures source 17. **Test-taking pearl**: Always check for upcoming surgeries or acute pain needs before prescribing naltrexone, as opioid blockade makes pain management dangerous and complex [15, 17]. Question 4. A 46-year-old man with a long history of severe alcohol use disorder presents to the outpatient clinic seeking detoxification assistance. Which historical factor in his medical record is most prominent in favoring inpatient hospitalization over outpatient detoxification? A) CIWA-Ar score of 12 B) History of alcohol use disorder for 2 years C) Comorbid mild major depressive disorder D) Prior history of delirium tremens Pause. Answer: D **Why it is correct**: A prior history of delirium tremens or withdrawal seizures is the most significant risk factor predicting severe, life-threatening withdrawal, strongly dictating inpatient medical hospitalization [22-25]. **Why the other choices are wrong**: - A is incorrect because a CIWA-Ar score under 15 indicates mild-to-moderate withdrawal that can often be managed safely in an outpatient setting with frequent monitoring [24, 26, 27]. - B is incorrect because a 2-year duration of alcohol use without severe withdrawal complications does not automatically require inpatient care [22, 24]. - C is incorrect because mild depression without active suicidal ideation can be managed in an outpatient dual-diagnosis treatment plan [22, 24]. **Test-taking pearl**: Delirium tremens and withdrawal seizures are medical emergencies; any history of DTs mandates inpatient admission for detoxification [22, 23, 25]. 💡 **Next Study Step**: Proceed to **Table 11-15 (Alcohol Withdrawal Protocols & CIWA-Ar Scoring)** to master acute withdrawal management and GABA/glutamate neurobiology. Next. New section. Long-Term Physical Effects (Table 11-9). Topic. Wernicke-Korsakoff Syndrome. Bottom Line. * **Wernicke encephalopathy** is an acute, reversible neurological emergency caused by severe **thiamine** (vitamin B1) deficiency, presenting with the classic triad of **delirium**, **ataxia**, and **ophthalmoplegia**. * **Korsakoff psychosis** (alcohol amnesic disorder) is a chronic, irreversible neurological condition resulting from inadequately treated Wernicke encephalopathy, characterized by retrograde and anterograde **amnesia**, **confabulation**, and lack of insight. * **First-line** intervention for acute alcohol withdrawal or suspected Wernicke encephalopathy requires administering parenteral **thiamine** prior to or concurrently with intravenous **glucose** to prevent precipitating or worsening encephalopathy. * Chronic heavy alcohol consumption contributes to long-term physical damage across nearly every body system, including **major neurocognitive disorder**, peripheral **neuropathy**, cardiomyopathy, cirrhosis, gastritis, GI bleeding, and elevated cancer risk. * Laboratory markers for heavy alcohol use include an **AST** greater than **ALT** ratio (typically within 3 times the upper limit of normal, resolving within 1 to 3 months of sobriety) and mild **macrocytosis** with an **MCV** greater than 96 fL without anemia (developing in 60 percent of heavy drinkers and resolving within 2 to 3 months of sobriety). * **Safety alert**: Administering glucose without thiamine in a thiamine deficient patient depletes remaining thiamine stores during carbohydrate metabolism, which can trigger irreversible neurological destruction. * **Board trap**: Confusing **confabulation** in Korsakoff syndrome with intentional lying or malingering; confabulation is an unconscious fabrication of memories to fill memory gaps. High-Yield Concepts and Long-Term Physical Effects. Wernicke Encephalopathy. - **What it is**: An acute, life-threatening, reversible neuro-psychiatric syndrome resulting from severe thiamine (vitamin B1) depletion caused by chronic alcohol misuse and poor intestinal nutrient absorption. - **Classic triad**: **delirium** (confusion and altered mental status), **ataxia** (gait imbalance and unsteadiness), and **ophthalmoplegia** (nystagmus and ocular motor nerve paralysis). - **First-line treatment**: Immediate high-dose parenteral **thiamine** supplementation. - **Critical sequence**: Always give **thiamine** before or alongside intravenous **glucose**. Thiamine acts as a mandatory co-enzyme in glucose metabolism; providing carbohydrate loads without thiamine rapidly consumes residual vitamin B1, causing acute neuronal cell death in the mammillary bodies and thalamus. - **Safety alert**: Never delay thiamine administration while awaiting lab results in patients with alcohol use disorder presenting with confusion, unsteady gait, or abnormal eye movements. Korsakoff Psychosis. - **What it is**: A chronic, persistent, largely irreversible neurocognitive disorder (alcohol amnesic disorder) arising as the late sequela of uncorrected or improperly treated Wernicke encephalopathy. - **Cardinal features**: Severe anterograde amnesia (inability to form new memories) and retrograde amnesia (loss of past memories), accompanied by profound **confabulation** and intact immediate recall. - **Confabulation mechanism**: The patient spontaneously creates plausible but false stories to cover blank spots in memory without intentional deceit or conscious awareness of lying. - **Prognosis**: Poor recovery rate once structural brain damage occurs in the diencephalon; treatment focuses on long-term abstinence, high-dose **thiamine** maintenance, and a supportive cognitive environment. Long-Term Physical Effects of Alcohol. When evaluating the systemic damage of moderate-to-heavy alcohol consumption listed in Fitzgerald Table 11-9: - **Neurologic system**: Chronic heavy drinking causes **dementia** or **major neurocognitive disorder**, stroke, peripheral **neuropathy**, myopathy, and epilepsy. Peripheral neuropathy is a frequent outpatient presentation causing distal bilateral burning pain and paresthesias in the lower extremities. - **Cardiovascular system**: Causes persistent **hypertension**, coronary heart disease, and alcoholic **cardiomyopathy**. - **Gastrointestinal system**: Promotes **cirrhosis**, gastritis, alcoholic hepatitis, upper GI bleeding, and esophageal varices. Intestinal mucosal damage leads to severe malabsorption of vital nutrients, particularly **vitamin B12** and **thiamine**. - **Oncology and neoplasm risks**: Increases cancer incidence across multiple sites, including the mouth, pharynx, esophagus, liver, pancreas, colon, rectum, prostate, ovaries, endometrium, bladder, and breast in women. - **Psychiatric comorbidity**: High rates of comorbid depression, anxiety, and elevated suicide risk. - **Fetal alcohol spectrum**: Maternal alcohol consumption during pregnancy leads to fetal alcohol syndrome and low birth weight. Laboratory Findings in Alcohol Misuse. - **Liver transaminases**: An **AST** greater than **ALT** ratio, usually within 3 times the upper limit of normal (for example, AST of 83 U/L and ALT of 50 U/L when the normal range is 0 to 40 U/L). This ratio resolves within 1 to 3 months of sustained sobriety. - **Macrocytosis**: Mild **macrocytosis** without anemia occurs in 60 percent of individuals consuming 3 or more drinks per day in women, or 5 or more drinks per day in men. Hemoglobin (15 g/dL) and hematocrit (45 percent) remain normal while **MCV** is elevated above 96 fL (for example, MCV of 105 fL; normal range 80 to 96 fL). This finding resolves within 2 to 3 months of sobriety. - **Triglycerides**: Isolated **hypertriglyceridemia** (for example, triglycerides of 325 mg/dL with a desirable level of 150 mg/dL or less) with normal HDL and LDL, resolving within 1 to 2 months of sobriety. Compare and Distinguish. Wernicke Encephalopathy vs. Korsakoff Psychosis. - **Do not confuse**: Acute reversible neurological emergency versus chronic irreversible neurocognitive syndrome. - **Think Wernicke encephalopathy when**: Patient presents with the acute triad of **delirium**, **ataxia**, and **ophthalmoplegia**. - **Think Korsakoff psychosis when**: Patient presents with chronic anterograde **amnesia**, **confabulation**, and apathy following chronic alcohol misuse. - **Priority difference**: Wernicke encephalopathy requires urgent parenteral **thiamine** before **glucose** to halt progression; Korsakoff psychosis requires long-term safety, cognitive support, and harm reduction because structural brain damage has already occurred. - **What boards are testing**: Recognizing the mandatory administration order (**thiamine** before **glucose**) and identifying **confabulation** as an unconscious defense mechanism rather than deliberate deception. - **Classic distractor**: Giving IV dextrose first in an intoxicated, confused patient before administering thiamine. Sample Practice Questions. Question 1. A 58-year-old man with a 20-year history of severe alcohol use disorder is brought to the emergency department by emergency medical services. He is disoriented to time and place, displays marked unsteadiness when attempting to walk, and exhibits horizontal nystagmus on extraocular movement examination. The medical team prepares to administer intravenous fluids containing dextrose. What is the most appropriate initial intervention by the PMHNP? A) Administer intravenous dextrose immediately to treat suspected hypoglycemia. B) Administer high-dose parenteral thiamine prior to starting the dextrose infusion. C) Order a STAT brain CT scan before administering any medications. D) Prescribe lorazepam to manage acute alcohol withdrawal delirium. Quick Answer. Administer high-dose parenteral thiamine prior to starting the dextrose infusion. Key Clue. Presence of the acute triad (disorientation, gait unsteadiness, nystagmus) requiring thiamine before carbohydrate administration. Best Answer. B) Administer high-dose parenteral thiamine prior to starting the dextrose infusion. Why It Is Correct. The patient exhibits the classic triad of **Wernicke encephalopathy**: **delirium**, **ataxia**, and **ophthalmoplegia**. Parenteral **thiamine** (vitamin B1) must be administered prior to or concurrently with intravenous **glucose** because thiamine is a required co-enzyme in glucose metabolism. Giving glucose alone to a thiamine-deficient patient depletes remaining thiamine stores, precipitating or worsening irreversible brain damage. Why the Other Choices Are Wrong. - **A:** Giving IV dextrose without thiamine exacerbates thiamine depletion and worsens acute neurological damage. - **B:** Correct choice. - **C:** Delaying thiamine for neuroimaging risks irreversible progression to Korsakoff psychosis. - **D:** Benzodiazepines treat alcohol withdrawal tremors or seizures but do not correct the underlying thiamine deficiency causing Wernicke encephalopathy. Test-Taking Pearl. Always give thiamine before or with glucose in patients with alcohol use disorder to prevent Wernicke-Korsakoff syndrome. Question 2. A 62-year-old male with a long history of chronic alcohol dependence is admitted to a residential facility. During the psychiatric intake interview, he describes detailed stories of working as a jet pilot yesterday, despite medical records showing he has been hospitalized for the past two weeks. He appears calm and unbothered when corrected. What clinical phenomenon is this patient demonstrating? A) Malingering B) Confabulation C) Persecutory delusion D) Delirium tremens Quick Answer. The patient is demonstrating confabulation. Key Clue. Fabricating detailed stories to fill memory gaps without intent to deceive. Best Answer. B) Confabulation Why It Is Correct. **Confabulation** is the unconscious fabrication of stories or facts to fill gaps in memory, characteristic of **Korsakoff psychosis** (alcohol amnesic disorder). The patient is not intentionally lying or seeking gain; rather, the damaged diencephalic memory circuits automatically construct plausible narratives to cover profound anterograde and retrograde **amnesia**. Why the Other Choices Are Wrong. - **A:** Malingering involves conscious, intentional fabrication of symptoms for primary gain, unlike unconscious confabulation. - **B:** Correct choice. - **C:** Persecutory delusions are fixed false beliefs that others are out to harm the patient, not memory gap filling narratives. - **D:** Delirium tremens presents with autonomic hyperarousal, severe tremors, fever, and vivid hallucinations, not calm memory gap filling. Test-Taking Pearl. Confabulation in Korsakoff syndrome is an unconscious memory defect, not intentional lying. Question 3. A 52-year-old woman presenting for routine psychiatric evaluation discloses drinking 4 glass equivalents of wine daily for 10 years. Complete blood count reveals a normal hemoglobin of 15 g/dL and normal hematocrit of 45 percent, but an MCV of 105 fL. Liver function testing shows AST of 83 U/L and ALT of 50 U/L. Which expectation should the PMHNP communicate regarding these lab findings? A) The elevated MCV indicates irreversible bone marrow damage. B) The transaminase ratio and MCV will resolve within 1 to 3 months of total sobriety. C) She requires immediate liver biopsy for suspected acute viral hepatitis. D) An elevated MCV with AST greater than ALT confirms acute Korsakoff psychosis. Quick Answer. The transaminase ratio and MCV will resolve within 1 to 3 months of total sobriety. Key Clue. Mild macrocytosis without anemia and AST greater than ALT ratio resolve with abstinence. Best Answer. B) The transaminase ratio and MCV will resolve within 1 to 3 months of total sobriety. Why It Is Correct. Mild **macrocytosis** without anemia (elevated **MCV** > 96 fL) develops in 60 percent of heavy drinkers and resolves within 2 to 3 months of sobriety. An elevated **AST** greater than **ALT** ratio within 3 times the upper limit of normal is characteristic of alcohol-induced liver strain and resolves within 1 to 3 months of sobriety. Why the Other Choices Are Wrong. - **A:** Alcohol-induced macrocytosis is reversible upon cessation of drinking and is not permanent bone marrow damage. - **B:** Correct choice. - **C:** An ALT greater than AST ratio suggests viral hepatitis, whereas AST greater than ALT points to alcohol etiology; biopsy is not initial protocol. - **D:** MCV and transaminase elevations reflect hematologic and hepatic effects of heavy drinking, not neurological Korsakoff psychosis. Test-Taking Pearl. MCV elevation without anemia is a key objective laboratory marker for chronic heavy alcohol use that reverses with 2 to 3 months of abstinence. Question 4. A 46-year-old male with alcohol use disorder is admitted for inpatient medically monitored withdrawal. He has a past medical history of alcohol withdrawal seizures and delirium tremens. Which intervention is most prominent in favoring inpatient hospitalization over outpatient detoxification? A) CIWA score of 10 B) History of alcohol use for 1 year C) Mild tremor on extension of arms D) Prior history of delirium tremens Quick Answer. A prior history of delirium tremens is the most prominent factor favoring inpatient hospitalization. Key Clue. Prior history of severe withdrawal complications like delirium tremens or seizures. Best Answer. D) Prior history of delirium tremens Why It Is Correct. A documented history of severe alcohol withdrawal complications, specifically **delirium tremens** or withdrawal seizures, is a major risk factor for complicated withdrawal and strongly favors inpatient hospitalization over outpatient detoxification. Why the Other Choices Are Wrong. - **A:** A CIWA score of 10 represents mild withdrawal and alone does not mandate inpatient hospitalization. - **B:** Duration of alcohol use alone is less predictive of life-threatening withdrawal than a past history of delirium tremens. - **C:** Mild tremors can be safely managed in outpatient or partial settings if severe withdrawal history is absent. - **D:** Correct choice. Test-Taking Pearl. A past history of delirium tremens or withdrawal seizures is the single strongest indicator for inpatient alcohol detoxification. Next Study Step. Review Fitzgerald Chapter 11 section on **Pharmacotherapy for Alcohol Dependence** (specifically comparing **acamprosate**, **naltrexone**, and **disulfiram**). Why This Is the Best Next Step. Mastering relapse prevention pharmacotherapy builds directly on understanding long-term alcohol pathology and safety contraindications, ensuring you can correctly match medications to patient comorbidities such as liver disease or planned opioid use on board exams. Next. Topic. Fetal Alcohol Syndrome (FAS). Bottom Line Summary. * **Fetal alcohol syndrome** (**FAS**) is the leading preventable cause of birth defects and neurodevelopmental impairment, caused by in utero exposure to alcohol. * Zero alcohol consumption during pregnancy is the national standard of care because no safe trimester, threshold, or quantity of alcohol consumption exists. * Chronic moderate to heavy alcohol consumption contributes to long-term pathology across every body system, including **major neurocognitive disorder**, **hypertension**, **cardiomyopathy**, **cirrhosis**, **esophageal varices**, and **peripheral neuropathy**. * Alcohol is a established carcinogen that increases the risk of **breast cancer** in women, as well as cancers of the mouth, oropharynx, esophagus, liver, pancreas, colon, and rectum. * Lab markers of heavy alcohol use include **macrocytosis** (**MCV** greater than 96 fL, typically around 105 fL) without anemia in 60% of heavy drinkers, and an **AST** to **ALT** ratio greater than 2 to 1. * Acute alcohol detoxification requires administering **thiamine** (**vitamin B1**) before any **glucose** infusion to prevent **Wernicke encephalopathy** and **Korsakoff psychosis**. * Pharmacotherapy for alcohol dependence includes **naltrexone** (reduces cravings, contraindicated in acute hepatitis or active opioid use) and **acamprosate** (restores **GABA** and **glutamate** balance, cleared renally, safe in liver disease). Fetal Alcohol Syndrome and Long-Term Physical Effects of Alcohol. Prenatal Exposure and Fetal Alcohol Syndrome. Prenatal alcohol exposure is a direct teratogen causing **fetal alcohol syndrome** (**FAS**). Alcohol readily crosses the placenta, altering fetal cellular differentiation, organogenesis, and neural development. Key clinical features include low birth weight, growth restriction, central nervous system dysregulation, cognitive impairment, behavioral disruption, and facial dysmorphology. Because a safe dose or timeline for alcohol consumption during gestation does not exist, complete abstinence remains the sole evidence-based guideline. **Safety alert**: Prenatal alcohol intake is the primary preventable cause of intellectual disability and structural birth defects. When evaluating pregnant women or individuals of childbearing age with alcohol use disorder, immediate screening, harm reduction, and complete abstinence planning are mandatory. If medical detoxification is required during pregnancy, inpatient admission with continuous fetal and maternal monitoring is essential. **Board trap**: Exam items may present a pregnant patient with alcohol dependence and tempt you to choose **disulfiram** or **naltrexone**. **Naltrexone** carries risks of precipitating opioid withdrawal if co-ingested and requires careful risk-benefit balance, while **disulfiram** is contraindicated due to toxic acetaldehyde accumulation and severe oxidative stress during an alcohol reaction. Non-pharmacologic interventions, specifically **motivational interviewing**, combined with obstetric co-management form the safest initial approach. **First-line**: The **first-line** intervention for pregnant individuals screened positive for alcohol use is immediate **motivational interviewing**, psychoeducation regarding zero-tolerance pregnancy standards, and rapid referral to perinatal substance use recovery services. Systemic Long-Term Physical Complications. Chronic moderate to heavy alcohol consumption leads to progressive structural and functional damage across all major organ systems: * **Neurologic system**: Chronic exposure causes **major neurocognitive disorder** (alcohol-induced dementia), **stroke**, **peripheral neuropathy** (presenting as lower extremity burning pain and numbness), **myopathy**, and **epilepsy** from chronic neurotoxicity and nutritional depletion. * **Gastrointestinal system**: Direct mucosal injury produces **gastritis**, **alcoholic hepatitis**, **cirrhosis**, **portal hypertension**, and **esophageal varices** with high mortality from GI bleeding. Damaged intestinal mucosa impairs nutrient absorption, leading to severe **thiamine** (**vitamin B1**) and **vitamin B12** deficiencies. * **Cardiovascular system**: Long-term use drives **hypertension**, **coronary heart disease**, and **alcoholic cardiomyopathy**. * **Neoplasms**: Alcohol significantly elevates malignant disease risk, including **breast cancer** in women, alongside cancers of the oral cavity, pharynx, esophagus, liver, pancreas, colon, rectum, prostate, and bladder. * **Psychiatric comorbidity**: Severe alcohol use disorder strongly correlates with co-occurring **major depressive disorder**, **anxiety disorders**, and a heightened risk of **suicide**. Fitzgerald Chapter 11 Sample Exam Questions. Question 1. Marcus, a 24-year-old law student at risk of failing out of school, is referred for evaluation. He drinks an average of 6 beers per night and had a DUI arrest last year. Marcus states: "I don't think my beer drinking has anything to do with my bad grades. I really only have a couple of beers every night, and it helps me relax." This statement represents which defense mechanism? A) Enabling B) Projection C) Psychological dependence D) Denial Pause. Answer: D. Why correct: **Denial** is the primary cognitive defense mechanism in substance use disorders where the patient minimizes consequences, refutes the connection between substance use and functional impairment, or insists outside treatment is unnecessary. Why the other choices are wrong: * **A:** Enabling is a behavior performed by loved ones or family members that accommodates or covers up the patient's substance use. * **B:** Projection involves attributing one's own unacceptable thoughts or feelings onto another person. * **C:** Psychological dependence refers to emotional cravings and taking a substance to avoid unpleasant mood states, rather than the cognitive denial of impairment. Question 2. Which PMHNP response to Marcus best exemplifies the principles of **motivational interviewing**? A) "Relaxing is important to you after you have worked hard at school." B) "Do you see your DUI as an indication that you likely have a problem with alcohol?" C) "Your advisor obviously thinks that your beer drinking is affecting your grades, which is why he referred you here." D) "What else could be causing your low grades then?" Pause. Answer: A. Why correct: **Motivational interviewing** utilizes reflective listening, empathy, and validation of the patient's perspective to explore ambivalence without confrontation or argument. Why the other choices are wrong: * **B:** Asking closed, confrontational questions about a DUI provokes defensiveness and breaks rapport. * **C:** Blaming the advisor or appealing to authority damages the therapeutic alliance. * **D:** Challenging the patient with a sarcastic counter-question increases resistance rather than building motivation for change. Question 3. Gary, a 54-year-old man with moderate liver disease, has maintained sobriety for 3.5 years. At his follow-up visit, he reports the recent death of his sibling and job loss, stating he has increased urges to drink. Which clinical principle applies? A) The risk of relapse is minimal due to his long period of established sobriety. B) Stressful life events can act as a powerful trigger for relapse regardless of length of sobriety. C) He should be hospitalized immediately to prevent a possible relapse. D) Limiting alcohol consumption to 2 to 3 drinks per day is an acceptable outcome. Pause. Answer: B. Why correct: Major life stressors, grief, and employment loss represent significant triggers that reactivate cravings and relapse risk even after years of sustained abstinence. Why the other choices are wrong: * **A:** Relapse risk persists long-term; assuming 3.5 years of sobriety eliminates risk is an unsafe assumption. * **C:** Immediate hospitalization is restrictive and unnecessary for outpatient craving management without active severe intoxication, withdrawal, or suicidality. * **D:** Recommending moderate drinking to a patient with alcohol dependence and liver disease is unsafe and violates treatment standards. Question 4. To help Gary prevent a relapse during this stressful period, which pharmacologic agent is most appropriate? A) Acamprosate B) Naloxone C) Clonidine D) Lorazepam Pause. Answer: A. Why correct: **Acamprosate** restores **GABA** and **glutamate** balance to reduce cravings in abstinent patients and is cleared renally, making it safe in moderate liver disease. Why the other choices are wrong: * **B:** **Naloxone** (**Narcan**) is an acute opioid reversal agent used for overdose, not for alcohol craving maintenance; **naltrexone** would be contraindicated or used with extreme caution in moderate to severe liver disease. * **C:** **Clonidine** is an alpha-2 agonist used for autonomic symptom control in opioid withdrawal, not chronic alcohol craving prevention. * **D:** **Lorazepam** is a benzodiazepine used for acute alcohol withdrawal detoxification, carrying high addiction and sedation risks if prescribed long-term for cravings. Question 5. Dana, a 44-year-old nurse completing 30 days of inpatient rehab for alcohol and methamphetamine dependence, wants to start medication to maintain abstinence. She has extensive dental surgery scheduled next month. Which medication is strictly contraindicated? A) Disulfiram B) Naltrexone C) Acamprosate D) Sertraline Pause. Answer: B. Why correct: **Naltrexone** is a mu-opioid receptor antagonist that blockades exogenous opioids. If prescribed prior to dental surgery, it will block necessary opioid analgesics or precipitate severe acute withdrawal if opioids are administered. Why the other choices are wrong: * **A:** **Disulfiram** is an aversion agent that does not block opioid analgesics. * **C:** **Acamprosate** works on **GABA** and **glutamate** and does not interact with opioid analgesics. * **D:** **Sertraline** is an **SSRI** antidepressant without opioid receptor blockade properties. Question 6. When deciding on the treatment setting for a 46-year-old man undergoing alcohol withdrawal, which historical factor is most prominent in favoring inpatient hospitalization? A) A CIWA score of less than 15 B) History of alcohol use disorder for 2 years C) Co-occurring major depressive disorder D) Prior history of delirium tremens Pause. Answer: D. Why correct: A history of **delirium tremens** (**DTs**) or withdrawal seizures is the strongest predictor of severe, life-threatening withdrawal complications, necessitating inpatient medical monitoring. Why the other choices are wrong: * **A:** A **CIWA-Ar** score under 15 indicates mild to moderate withdrawal that can typically be managed safely in outpatient or ambulatory settings. * **B:** A 2-year duration of alcohol use without severe past withdrawal complications does not automatically require inpatient admission. * **C:** Uncomplicated co-occurring depression can be managed in outpatient settings unless acute active suicidality is present. Question 7. In a patient presenting with acute alcohol withdrawal, why must **thiamine** (**vitamin B1**) be administered prior to **glucose** fluids? A) Glucose inhibits thiamine absorption in the gastrointestinal tract. B) Thiamine is a required co-factor for glucose metabolism, and glucose loading without thiamine precipitates acute Wernicke encephalopathy. C) Glucose causes rapid hepatic metabolism of thiamine. D) Thiamine prevents acute hypoglycemia caused by alcohol intoxication. Pause. Answer: B. Why correct: **Thiamine** is a necessary co-factor for enzymes in glucose carbohydrate metabolism. Giving **glucose** to a thiamine-deficient alcohol-dependent patient consumes remaining thiamine stores, precipitating acute **Wernicke encephalopathy**. Why the other choices are wrong: * **A:** Intravenous glucose administration does not alter gastrointestinal absorption of thiamine. * **C:** Glucose does not accelerate hepatic degradation of thiamine. * **D:** Thiamine does not regulate blood glucose levels or directly reverse hypoglycemia. 💡 Would you like to proceed next to a high-yield review of Chapter 12 (Personality Disorders) or explore specific pharmacotherapy algorithms for substance use management? Next. End of this drive.